|
Encore Therapeutics Inc. Announces Successful Proof of Concept Study on Meloxi cam Depot Injection (Octorber 18, 2011)
Encore Therapeutics Inc. Announces Extended Release Depot Formulation of Ropivacaine Available for License (September 26, 2011)
Progesterone and TBI: Encore Therapeutics Inc. Completes Novel Commercially Enabling Progesterone Formulation for TBI (May 10, 2011)
Encore Therapeutics Inc. Announces Depot Meloxicam Formulation Enabling Local High Drug Dose Delivery (April 4, 2011)
Encore Therapeutics Inc. Reports Efficacy Data on a Long-Acting Local Anesthetic Drug (January 30, 2007).
Novel Progesterone Formulation for Stroke and Traumatic Brain Injury Developed by Encore Therapeutics (June 24, 2008) .
PainReform Licenses a Novel Sustained Release Formulation of Ropivacaine from Encore Therapeutics Inc. (July 2, 2008). |
|
